Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Dummy, Double-blind Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults

NCT05351086 is registered in ClinicalTrials.gov with Pulmatrix Inc. as lead sponsor.

NCT NCT05351086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05351086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Dummy, Double-blind Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults
Lead sponsor
Pulmatrix Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 9, 2022
Completion date
September 22, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy